Presurgical Phase IIB Trial of Oral CDB-4124 vs. Placebo in Women with Stage 0-II Primary Breast Cancer: PACT-B (Progesterone Antagonists for Cancer Treatment for Breast) Study
Latest Information Update: 04 Mar 2022
At a glance
- Drugs Telapristone (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- 16 Jan 2020 Planned End Date changed from 1 Mar 2020 to 1 Mar 2022.
- 16 Jan 2020 Planned primary completion date changed from 1 Feb 2019 to 1 Jun 2021.
- 30 Sep 2019 Results published in the Clinical Cancer Research